Patents by Inventor Roberto Maldonado

Roberto Maldonado has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240195535
    Abstract: Example embodiments of the present disclosure relate to de-prioritization of retransmission. A device determines whether user data is absent in a transport block that is to be retransmitted through a hybrid automatic repeat request process. The device deprioritizes selection of the hybrid automatic repeat request process for one or more transmissions on a configured grant based at least in part on the determination. Through this solution, it is possible to avoid or deprioritize unnecessary retransmissions of the transport blocks without user data.
    Type: Application
    Filed: March 30, 2021
    Publication date: June 13, 2024
    Applicant: NOKIA TECHONOLOGIES OY
    Inventors: Ping-Heng KUO, Chunli WU, Zexian LI, Roberto MALDONADO
  • Patent number: 11997644
    Abstract: There are provided measures for handling of paging messages in communication endpoint to network relaying scenarios.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: May 28, 2024
    Assignee: Nokia Technologies Oy
    Inventors: Lianghai Ji, Frank Frederiksen, Claudio Rosa, Erika Portela Lopes De Almeida, Morten Toft, Johannes Hejselbaek, Faranaz Sabouri-Sichani, Bo Holm Bjerrum, Samantha Caporal Del Barrio, Roberto Maldonado
  • Publication number: 20240156955
    Abstract: This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.
    Type: Application
    Filed: June 6, 2023
    Publication date: May 16, 2024
    Applicant: Selecta Biosciences, Inc.
    Inventors: Christopher Fraser, Grayson B. Lipford, Christopher J. Roy, Roberto A. Maldonado
  • Publication number: 20240008072
    Abstract: There are provided measures for enabling/realizing support for idle period communication in semi-static channel access. Such measures exemplarily comprise that a user equipment device monitors for presence of a clearance indication provided by a base station device serving the user equipment device, which indicates clearance for communication by the user equipment device in at least one idle period of abase station device frame period, disables communication by the user equipment device in the at least one idle period of the base station device frame period when the monitoring yields absence of the clearance indication, and enables communication by the user equipment device in the at least one idle period of the base station device frame period when the monitoring yields presence of the clearance indication.
    Type: Application
    Filed: August 30, 2021
    Publication date: January 4, 2024
    Inventors: Renato Barbosa ABREU, Claudio ROSA, Roberto MALDONADO, Morten TOFT, Timo Erkki LUNTTILA
  • Patent number: 11860995
    Abstract: A method to implement traceability and provability on a particular project in software development based on blockchain-recorded transactions of assigned developer time, the method comprising of the following steps: setting up a blockchain network comprised of a distributed, redundant, and tamper-resistant ledger; issuing each user an attestable pre-fabricated and signed virtualized environment on approved hardware that comes with functionality required for the user's role implemented as one of a set of virtual machine templates fashioned from a signed and approved pre-fabricated image; and verifying that assigned developer time is valid, and if so, record each development action on the ledger to enable extensive tracking and auditing of end-to-end software development process.
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: January 2, 2024
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Russell Shannon, Joseph Garcia, Aaron Jacobson, William Mosca, Roberto Maldonado, Michael Burger
  • Patent number: 11849509
    Abstract: An apparatus, provided in use in a first device comprises at least one processor and at least one memory including a computer program code, the at least one memory and computer program code configured to, with the at least one processor, cause the apparatus at least to: receive first information about a context provided by a controller, said first information being received from a base station; and cause the first device to transmit one or more ping messages to one or more second devices, said one or more ping messages comprising information about said context which causes one or more second devices to reply to the controller.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: December 19, 2023
    Assignee: Nokia Technologies Oy
    Inventors: Karsten Aarrebo Petersen, Bent Henneberg Rysgaard, István Zsolt Kovács, Troels Emil Kolding, Roberto Maldonado
  • Publication number: 20230397241
    Abstract: An apparatus, method and computer program product for: performing channel availability monitoring on an operating channel for transmitting uplink control information for transmitting a data packet, in response to determining that the operating channel is available for transmitting the uplink control information, determining delay information relating to the channel availability monitoring, and transmitting the uplink control information and the delay information to the radio access network.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 7, 2023
    Inventors: Claudio ROSA, Morten TOFT, Renato Barbosa ABREU, Daniela LASELVA, Ali KARIMIDEHKORDI, Roberto MALDONADO
  • Publication number: 20230321225
    Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising therapeutic protein APC presentable antigens and immunosuppressants that provide tolerogenic immune responses specific to therapeutic proteins.
    Type: Application
    Filed: March 2, 2023
    Publication date: October 12, 2023
    Applicant: Selecta Biosciences, Inc.
    Inventors: Christopher Fraser, Takashi Kei Kishimoto, Roberto A. Maldonado
  • Publication number: 20230321224
    Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class II-restricted epitopes and immunosuppressants that provide tolerogenic immune responses, such as a reduction in CD4+ T cell help specific to an antigen.
    Type: Application
    Filed: December 8, 2022
    Publication date: October 12, 2023
    Applicant: Selecta Biosciences, Inc.
    Inventors: Christopher Fraser, Takashi Kei Kishimoto, Roberto A. Maldonado
  • Patent number: 11780112
    Abstract: Binders, methods for making same, and methods for making composite lignocellulose products therefrom. The binder can include about 30 wt % to about 40 wt % of solids that include a urea-modified aldehyde-based resin; about 0.1 wt % to about 3 wt % of solids that include an isocyanate-based resin; about 0.1 wt % to about 12 wt % of an extender; and about 50 wt % to about 62 wt % of water, where all weight percent values are based on a total weight of the binder. The binder can have a sodium hydroxide equivalent weight alkalinity of about 3 wt % to about 9 wt %.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: October 10, 2023
    Inventors: Juan José Joaquin Valenzuela Valdés, Ildolfo Alfonso Duran Retamal, Carlos Roberto Maldonado Rodríguez, Bobby Lee Williamson
  • Patent number: 11779641
    Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising immunosuppressants and MHC Class II-restricted epitopes of an allergen that provide tolerogenic immune responses specific to the allergen.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: October 10, 2023
    Assignee: Selecta Biosciences, Inc.
    Inventors: Takashi Kei Kishimoto, Christopher Fraser, Roberto A. Maldonado
  • Publication number: 20230310593
    Abstract: Disclosed are synthetic nanocarrier compositions, and related methods, comprising immunosuppressants and MHC Class II-restricted epitopes of an allergen that provide tolerogenic immune responses specific to the allergen.
    Type: Application
    Filed: December 9, 2022
    Publication date: October 5, 2023
    Applicant: Selecta Biosciences, Inc.
    Inventors: Takashi Kei Kishimoto, Christopher Fraser, Roberto A. Maldonado
  • Patent number: 11717569
    Abstract: This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: August 8, 2023
    Assignee: Selecta Biosciences, Inc.
    Inventors: Christopher Fraser, Grayson B. Lipford, Christopher J. Roy, Roberto A. Maldonado
  • Publication number: 20230199835
    Abstract: A transmitter is configured to set a counter to a starting value, sense whether a channel is busy or idle and to update the counter value during sensing. When there is data to be transmitted, the transmitter is configured to determine, based on at least the counter value at a transmit opportunity and a duration the channel has been sensed idle before the transmit opportunity, whether to transmit the data or to continue the sensing the channel to a next transmit opportunity without reset- ting the counter value to the starting value.
    Type: Application
    Filed: May 6, 2021
    Publication date: June 22, 2023
    Applicant: Nokia Technologies Oy
    Inventors: Morten TOFT, Claudio ROSA, Mika KASSLIN, Olli ALANEN, Roberto MALDONADO
  • Publication number: 20230048589
    Abstract: A method to implement traceability and provability on a particular project in software development based on blockchain-recorded transactions of assigned developer time, the method comprising of the following steps: setting up a blockchain network comprised of a distributed, redundant, and tamper-resistant ledger; issuing each user an attestable pre-fabricated and signed virtualized environment on approved hardware that comes with functionality required for the user's role implemented as one of a set of virtual machine templates fashioned from a signed and approved pre-fabricated image; and verifying that assigned developer time is valid, and if so, record each development action on the ledger to enable extensive tracking and auditing of end- to-end software development process.
    Type: Application
    Filed: August 13, 2021
    Publication date: February 16, 2023
    Inventors: Russell Shannon, Joseph Garcia, Aaron Jacobson, William Mosca, Roberto Maldonado, Michael Burger
  • Publication number: 20230032226
    Abstract: Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity.
    Type: Application
    Filed: March 9, 2022
    Publication date: February 2, 2023
    Applicant: Selecta Biosciences, Inc.
    Inventor: Roberto A. Maldonado
  • Publication number: 20220354947
    Abstract: Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen in some embodiments.
    Type: Application
    Filed: December 16, 2021
    Publication date: November 10, 2022
    Applicant: Selecta Biosciences, Inc.
    Inventors: David H. Altreuter, Aaron P. Griset, Roberto A. Maldonado
  • Publication number: 20220322283
    Abstract: There are provided measures for handling of paging messages in communication endpoint to network relaying scenarios.
    Type: Application
    Filed: July 23, 2019
    Publication date: October 6, 2022
    Inventors: Lianghai JI, Frank FREDERIKSEN, Claudio ROSA, Erika PORTELA LOPES DE ALMEIDA, Morten TOFT, Johannes HEJSELBAEK, Faranaz SABOURI-SICHANI, Bo Holm BJERRUM, Samantha CAPORAL DEL BARRIO, Roberto MALDONADO
  • Patent number: 11298342
    Abstract: Disclosed are methods and related compositions for concomitantly, locally administering immunosuppressants and doses of therapeutic macromolecules for reducing Type I and Type IV hypersensitivity.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: April 12, 2022
    Assignee: Selecta Biosciences, Inc.
    Inventor: Roberto A. Maldonado
  • Patent number: 11235057
    Abstract: Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen in some embodiments.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: February 1, 2022
    Assignee: Selecta Biosciences, Inc.
    Inventors: David H. Altreuter, Aaron P. Griset, Roberto A. Maldonado